The Dutch National Growth Fund (NGF) has invested €124,5 million in a new centre for animal-free biomedical testing. The Ombion Centre for Animal-Free Biomedical Translation will use this funding from the NGF to accelerate the transition to animal-free biomedical innovations. This will offer economic and social benefits with improved medicines and less animal testing.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- http://www.ombion-cpbt.nl
- Keywords
- Regenerative Medicine.
Ombion Centre For Animal-Free Biomedical Translation Questions
Ombion Centre For Animal-Free Biomedical Translation's website is http://www.ombion-cpbt.nl
Ombion Centre For Animal-Free Biomedical Translation's LinkedIn profile is https://www.linkedin.com/company/cpbt
Ombion Centre For Animal-Free Biomedical Translation has
4 employees.
View email and phone details for 4
employees at Ombion Centre For Animal-Free Biomedical Translation.
Ombion Centre For Animal-Free Biomedical Translation's industry is
Public Health
Ombion Centre For Animal-Free Biomedical Translation's top competitors are
Biotech Booster,
Lumc - Regenerative Medicine,
Regmed Xb,
Netherlands National Committee For The Protection Of Animals Used For Scientific Purposes (Ncad),
To The Point - Trainingsbureau,
Regenl,
Azar Innovations,
Proefdiervrij,
Regenerative Medicine Utrecht,
Mimetas.
Ombion Centre For Animal-Free Biomedical Translation's categories are Public Health
Ombion Centre For Animal-Free Biomedical Translation's founding year is 2024
